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ABSTRACT
Introduction: Patients undergoing laparoscopic cholecystectomy do experience postoperative pain, es-
pecially in the abdomen. Postoperative pain management remains a major challenge after laparoscopic 
procedures. Administration of intraperitoneal local anesthetic (IPLA) after surgery is used as a method of 
reducing postoperative pain. In this study, we evaluated the effect of intraperitoneal infiltration of local 
anesthetic (bupivacaine) for pain relief after laparoscopic cholecystectomy.
Material and methods: In this prospective, controlled, and randomized study were included 50 patients 
aged 25-60 years (35 female and 15 male), scheduled to laparoscopic cholecystectomy with ASA classi-
fication 1 and 2. Patients were classified randomly into two groups: group A, which included 25 patients 
who received intraperitoneal instillation of bupivacaine 0.5% 20 ml; and group B, which included 25 pa-
tients who didn’t receive any intraperitoneal instillation. Postoperative pain was recorded using the visual 
analogue scale (VAS) for 24 hours after laparoscopic cholecystectomy.
Results: There was no significant difference with respect to age, weight, and sex; duration of surgery; and 
anesthesia time. VAS scores at different time intervals were statistically significantly lower at all times in 
group A compared to group B. There were statistically significant differences in VAS scores between group 
A and group B at all postoperative time points - 1hr,4 hr,8 hr,12hr and 24hr (p < 0.00001).
Conclusion: Intraperitoneal instillation of bupivacaine provides good analgesia in the postoperative period 
after laparoscopic cholecystectomy.
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EFFICACY OF INTRAPERITONEAL BUPIVACAINE  
ON PAIN RELIEF AFTER LAPAROSCOPIC CHOLECYSTECTOMY
Laparoscopic cholecystectomy (LC) is 
nowadays established as a gold standard form 
of treating patients with cholelithiasis. Laparo-
scopic cholecystectomy is a minimally invasive 
technique and is associated with reduced surgi-
cal trauma, smaller and more cosmetic incision, 
reduced blood loss, and is associated usually 
with fewer postoperative complications and de-
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creased length of hospital stay. [1] Although pain 
after LC is less intense than after open cholecys-
tectomy (OC), some patients still experience 
considerable discomfort and pain during the first 
24 to 72 postoperative hours. [2]
Postoperative pain remains the most prev-
alent complaint after laparoscopic cholecystecto-
my. This can prolong hospital stay, which is par-
ticularly of utmost importance since many cen-
ters are performing this operation as a day-case 
procedure. [3] Postoperative pain management 
remains a major challenge after laparoscopic pro-
cedures. Effective pain control encourages early 
ambulation, which significantly reduces the risk 
of deep vein thrombosis and pulmonary embo-
lism (PE); enhances patient’s ability to take deep 
breaths to decrease the risk of pulmonary com-
plications (e.g., atelectasis and pneumonia); and 
decreases the incidence of tachycardia and un-
necessary investigations related to it. Pain after 
laparoscopic surgery has a visceral component, 
as a result of surgical handling and diaphragmat-
ic irritation by dissolved carbon dioxide and a 
somatic component due to the holes made in the 
abdominal wall for the troacars. Shoulder pain, 
which is associated with peritoneal insufflations, 
occurs especially when shoulder holders and an 
exaggerated Trendelenburg position are used 
that frequently complicate the postoperative pe-
riod after the laparoscopic surgery. [4] Pain on 
the day of surgery is typically a diffuse abdomi-
nal pain, and more so to the right upper quadrant 
and right shoulder tip. [2]
Many methods have been proposed to 
improve pain control such as the use of local 
anesthetics at the troacar site, intraperitoneal 
injection of local anesthetics, intermittent intra-
venous non-steroidal anti-inflammatory drugs 
(NSAIDs), intermittent intramuscular narcotics, 
decreasing pneumoperitoneum pressure, and 
decreasing the number of operative ports. [5, 6] 
Administration of intraperitoneal local anesthet-
ic (IPLA) after surgery is used by many surgeons 
as a method of reducing postoperative pain. The 
method of delivering local anesthetic directly to 
the intraperitoneal cavity was first described in 
1951 by Griffin et al. [7] This method was for-
gotten for decades until its implementation in 
minimal access surgery was rekindled. Based on 
level A evidence it is now accepted that IPLA 
significantly reduces postoperative pain and opi-
oid use after laparoscopic general surgical pro-
cedures, open hysterectomy, and laparoscopic 
gynecological procedures. [8]
In this prospective, randomized, and con-
trolled study, we evaluated the effect of intraperi-
toneal infiltration of local anesthetic (bupivacaine) 
for pain relief after laparoscopic cholecystectomy.
MATERIAL AND  METHODS
In this prospective, controlled, and ran-
domized study were included 50 patients aged 
25-60 years (35 female and 15 male), scheduled 
for laparoscopic cholecystectomy with ASA 
classification 1 and 2. After approval from the 
local ethics committee and after obtaining in-
formed consent from each patient, the study 
was performed at the University Clinic for An-
esthesia, Reanimation and Intensive Care-KAR-
IL, Clinical Campus “Mother Teresa” – Skopje, 
during October 2016 to March 2017. From this 
study were excluded patients with ASA classifi-
cation 3-5, history of allergy to bupivacaine, ke-
tonal, and tramadol, patients with coagulopathy, 
and patients with a history of abdominal surgery. 
During the preoperative visit, the visual ana-
logue scale (VAS) ranging from 0 (no pain) to 
10 (worst imagined pain) was explained to every 
patient. The laparoscopic cholecystectomy and 
the intraperitoneal application of bupivacaine 
were performed by one surgeon. 
For all patients anesthesia was induced in-
travenously using midazolam 0.04 mg/kg, fenta-
ny l 0.002 mg/kg, propofol 1-2 mg/kg and rocu-
ronium 0.6 mg/kg and was maintained by using 
sevoflurane MAC 1 combined with oxygen : air 
(50 : 50) and additional boluses of fentanyl and 
rocuronium, as required. After tracheal intuba-
tion an orogastric tube was placed. All patients 
were continuously monitored by both lead II 
and V5 ECG, repeated non-invasive mean arte-
rial blood pressure (MAP) measurement every 
5 minutes, and continuous end-tidal CO2 and 
oxygen saturation (SpO2) by pulse oxymetry. 
End-tidal CO2 was maintained between 35 and 
45 mmHg. During laparoscopy, intraabdominal 
pressure of all patients was maintained at 12 
mmHg with continuous CO2 insufflation. Addi-
tionally, fentanyl 0.5-1 microgr/kg was injected 
to control blood pressure and heart rate within 
20% of baseline. Patients were classified ran-
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domly into two groups: group A, which included 
25 patients who received intraperitoneal instil-
lation of bupivacaine 0.5% 20 ml; and group B, 
which included 25 patients who didn’t receive 
any intraperitoneal instillation. Bupivacaine was 
instilled immediately after laparoscopic removal 
of the gallbladder and after performing complete 
washing of the peritoneal cavity and aspiration 
of the solution used for irrigation and before 
wound closure, under the visual guidance of lap-
aroscopic camera. During the study, prophylac-
tic antiemetics were not given. 
At the end of the surgery, the abdomen was 
completely deflated, and muscle relaxation was 
reversed with intravenous (i.v.) neostigmine 0.05 
mg/kg and atropine 0.01 mg/kg. No analgesics 
were given to patients before recovery. After the 
surgery, patients were taken to postanesthesia 
care unit (PACU). The anaesthesiologist follow-
ing up the patient was blinded to the groups. The 
time of arrival at the PACU was defined as zero 
(0) hour postoperatively. The intensity of post-
operative abdominal pain was assessed using a 
VAS, with evaluation at 1, 4, 8, 12, and 24 hours 
postoperatively. In patients with VAS score 
above 4, 100 mg of ketonal was administered 
i.v., while in patients with VAS score above 7, 
100 mg of tramadol was administered intramus-
cular (i.m.) as rescue analgesia treatment. Post-
operative nausea and vomiting (PONV) were 
planned to be treated with ondansetron 4 mg i.v.
Postoperative abdominal pain intensity in the 
follow-up period of 24 h was compared for both 
groups. The patients were observed for side effects 
such as pruritus, sedation, bradycardia, hypoten-
sion, and shivering during the follow-up period.
Data analysis was performed by using Sta-
tistical Package for Social Sciences (SPSS) ver-
sion 17.0 software. Kolmogorov Smirnov test 
and Shapiro-Wilk’s W test were used to identify 
the distribution of variables. Data were expressed 
as mean ± standard deviation. Student t –test for 
independent groups was used for numerical vari-
ables with normal distribution, and the Mann–
Whitney U test was used for nonparametric vari-
ables. A p-value less than 0.05 was considered 
statistically significant.
RESULTS
There was no significant difference with 
respect to age, weight, and sex; duration of sur-
gery; and anesthesia time (Table 1).
Table 1. Demographic and clinical characteristics
Variable Group A 
(N=25)
Group B 
(N=25)
P-value
Age / years 42.4 ± 7.6 45.3 ± 10.2 p = 0.2626
Weight / kg 84.6 ± 9.9 83.5 ± 12.7 p = 0.7431
Sex (M/F), 
number
8/17
(32% / 68%)
7/18
(28% / 72%)
p = 0.7599
Duration 
of surgery 
(minutes)
41.4 ± 10.7 37.6  ± 5.3 p = 0.2859
Anesthesia 
time (minutes)
50.7 ± 14.5 53.5 ± 5.4 p = 0.0572
VAS scores at different time intervals were 
statistically significantly lower at all times in 
group A compared to group B (Table 2). There 
were statistically significant differences in VAS 
scores between group A and group B at all post-
operative time points - 1 hr, 4 hr, 8 hr, 12hr and 
VAS 1 h VAS 4 h VAS 8 h VAS 12 h VAS 24 h
Group A 2.04 ± 0,67
Group B 5.56 ± 1.35  
p < 00001 
Group A 2.64 ± 0.75
Group B 5.68 ± 1.28     
p < 00001
Group A 2.56± 1.0
Group B 4.80 ± 0.91   
p < 00001
Group A 1.76 ± 0.88
Group B 4.24 ± 0.97   
p<00001 
Group A 0.76 ± 0.72
Group B 3.44 ± 0.58    
p < 00001
Table 2. VAS scores in group A and B at all postoperative time points
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24 hr (p < 0.00001).VAS scores in group А were 
significantly lower (Table 2 and Figure 1).
In the postoperative period, none of the pa-
tients from group A complained for side effects 
of local anesthetics, such as pruritus, sedation, 
bradycardia, hypotension, and shivering. 
Postoperative time point
 Mean 
 Mean±SE 
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Figure 1. VAS scores in group A and B at all 
postoperative time points
DISCUSSION
Pain after laparoscopic cholecystectomy 
is less intense and lasts a shorter time, compared 
to pain after open cholecystectomy. [9] This ex-
plains why patients can be discharged within the 
first postoperative day of LC surgery and can re-
turn to their normal daily activities more quickly, 
compared to open cholecystectomy. However, LC 
is not a pain-free procedure. Postoperative pain 
control is directed at early mobilization, recovery, 
and discharge. Pain can play a major role in met-
abolic and endocrine responses and can impair 
postoperative pulmonary function. [5] Several 
mechanisms of postlaparoscopic pain generation 
have also been proposed such as ruptured blood 
vessels resulting from the rapid distension of the 
peritoneum, traumatic nerve traction, release of 
inflammatory molecules, trauma to the abdom-
inal wall, trauma occurring with the removal of 
the gallbladder from the abdomen, pneumoperi-
toneum created by utilizing CO2, maintenance of 
high abdominal pressure, irritation of the phren-
ic nerve, and application of cold CO2. [10] Rec-
ommendations for the treatment of postoperative 
pain in patients undergoing LC include NSAIDs, 
local anesthesia injection at the incision sites, opi-
oids, and preoperative steroid use. [5]
Intraperitoneal local anesthetics (IPLAs) 
have been used since 1951. [7] IPLA has been 
used to reduce shoulder tip pain, overall pain, nau-
sea and vomiting, and the time of hospital stay. 
[11] Based on level A evidence, it is now accepted 
that IPLA significantly reduces postoperative pain 
and opioid use after laparoscopic general surgical 
procedures, [11] open hysterectomy, [12] and lap-
aroscopic gynecological procedures. [13] There 
are several mechanisms of IPLA that have been 
postulated. IPLA is likely to blockade free affer-
ent nerve endings in the peritoneum. Systemic 
absorption of local anesthetic from the peritoneal 
cavity may also play a part in reduced nociception 
although this would be expected to occur after any 
local anesthetic technique. Systemic levels of lo-
cal anesthetic are detectable in the serum circula-
tion as soon as 2 minutes after bolus instillation 
into the peritoneum. [8]
In this study, intraperitoneal instillation of 
bupivacaine 0.5% 20 ml significantly reduced the 
postoperative pain and significantly reduced the 
analgesics requirement in the postoperative peri-
od. There was no significant difference with re-
spect to age, weight, and sex; duration of surgery; 
and anesthesia time. VAS scores at different time 
intervals were statistically significantly lower at 
all times in group A compared to group B (Table 
2). There were statistically significant differences 
in VAS scores between group A and group B at all 
postoperative time points - 1 hr, 4 hr, 8 hr, 12 hr 
and 24 hr (p < 0,00001). VAS scores in group А 
were significantly lower (Table 2 and Figure 1). In 
the postoperative period none of the patients from 
group A complained for side effects of local an-
esthetics, such as pruritus, sedation, bradycardia, 
hypotension, and shivering.
Banoria et al., in his study included 64 pa-
tients scheduled for LC, divided in two groups. 
Group A patients were instilled intraperitoneal-
ly using 20 ml of 0.5% injection bupivacaine in 
diaphragmatic surface and gallbladder fossa just 
after LC and Group B patients were not instilled 
with any injection. They found that the early post-
operatively VAS scores and pain intensity after 8 
hrs and 16 hrs is decreased with the use of intra-
peritoneal instillation of injection bupivacaine, 
but in the long term, it offers no added benefit to 
the postoperative pain relief and does not decrease 
the need for analgesia postoperatively. [6] 
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The study of Jamal et al., included 90 pa-
tients scheduled for LC, divided into 3 groups. 
Patients in group T received tramadol 2 mg/kg in 
30 ml normal saline, in group B received bupiva-
caine 30 ml of 0.125% and in group BT received 
tramadol 2 mg/kg in 30 ml of 0.125% bupivacaine 
intraperitoneally. The result was that intraperito-
neal application of bupivacaine with tramadol 
was a more effective method for postoperative 
pain control after LC compared to intraperitoneal 
bupivacaine or tramadol alone. [14]
Another study consisted of 66 patients 
scheduled for LC. Group BS received 15 ml of 
0.25% levobupivacaine before troacar site in-
cision and 40 ml of 0.25% levobupivacaine in-
traperitoneally immediately after the creation of 
pneumoperitoneum. Group AS received the same 
doses of incisional levobupivacaine at the end of 
the operation and intraperitoneal levobupivacaine 
before the troacars were withdrawn. Group C re-
ceived no treatment. The combination of incision-
al and intraperitoneal levobupivacaine adminis-
tered before or after surgery can reduce postoper-
ative pain and analgesic and antiemetic consump-
tion together with improved patient satisfaction. 
Administering levobupivacaine before surgery 
might be advantageous for less intraoperative 
fentanyl consumption, while levobupivacaine af-
ter surgery is advantageous for less postoperative 
rescue analgesic requirement. [3] Morsy at al., in 
his study included 80 patients scheduled for LC, 
divided into three groups. Group C received 50 ml 
normal saline intraperitoneally; Group L received 
200 mg lidocaine intraperitoneally; and Group N 
received 10 mg nalbuphine intraperitoneally in 
50 ml normal saline. Although both lidocaine and 
nalbuphine when used intraperitoneally produce 
postoperative analgesia, intraperitoneal lidocaine 
gives a better analgesic profile with fewer un-
wanted effects. [1]
Khan et al., used both lidocaine and bu-
pivacaine intraperitoneally during laparoscopic 
cholecystectomy for postoperative analgesia and 
concluded that bupivacaine and lidocaine are both 
safe and equally effective in decreasing postoper-
ative pain after LC. [15] Some studies evaluated 
the efficacy of intraperitoneal and intravenous li-
docaine on pain relief after LC and they reported 
significantly reduced postoperative pain and opi-
oid consumption in LC patients, compared with 
control infusions. [16] Another study evaluated 
intraperitoneal instillation of 30 ml 0.2% ropiva-
caine (R group) versus intraperitoneal instillation 
of 30 ml 0.2% ropivacaine combined with 1 μgr/
kg dexmedetomidine (RD group) and they re-
ported significantly reduced VAS scores in 24 hrs 
postoperatively, time to first request of analgesia 
was longest and total analgesic consumption was 
lowest in RD group compared to R group. [4]
 
CONCLUSION
Intraperitoneal instillation of bupivacaine 
provides good analgesia in the postoperative 
period after laparoscopic cholecystectomy. Our 
study showed this technique to be an effective 
alternative method for early pain control and to 
minimize the need of opioid analgesics in the 
postoperative period. It is easy to be adminis-
tered with no adverse effects, cheap and nonin-
vasive method, and may become a routine prac-
tice for this procedure.
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Резиме
ЕФЕКТОТ НА ИНТРАПЕРИТОНЕАЛНО ДАДЕНИОТ BUPIVACAINE ВО НАМАЛУВАЊЕ 
НА БОЛКАТА ПО ЛАПАРОСКОПСКА ХОЛЕЦИСТЕКТОМИЈА 
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Вовед: Пациентите што се предвидени за лапароскопска холецистектомија имаат постоперативна 
болка, особено во стомакот. Третманот на болката во постоперативниот период сѐ уште е голем 
предизвик по лапароскопските операции. Давањето локален анестетик интраперитонеално (IPLA) 
по операцијата се користи како метод со кој се намалува постоперативната болка. Во оваа студија 
го оценуваме ефектот на интраперитонеалната инфилтрација на локален анестетик (bupivacaine) за 
намалување на болката по лапароскопска холецистектомија.
Материјал и методи: Во оваа проспективна, контролирана и рандомизирана студија беа 
вклучени 50 пациенти, на возраст од 25 до 60 години (35 жени и 15 мажи), предвидени за лапароскопска 
холецистектомија, со ASA класификација 1 и 2. Пациентите беа рандомизирани во две групи: група 
А, која вклучува 25 пациенти на кои им беше дадено 20 ml 0,5% bupivacaine интраперитонеално; 
и група Б, која вклучува 25 пациенти на кои не им беше дадено ништо интраперитонеално. Беше 
следена постоперативната болка со користење визуелна аналогна скала за болка (VAS) за 24 часа 
по лапароскопска холецистектомија.
Резултати: Немаше значителна разлика во однос на возраста, тежината и полот, траењето 
на операцијата и траењето на анестезијата. VAS-скоровите во различни временски интервали беа 
статистички значително пониски во сите времиња кај групата А во споредба со групата Б. Имаше 
статистички значителни разлики во VAS-скоровите меѓу групата А и групата Б во сите времиња во 
постоперативниот период – 1, 4, 8, 12 и 24 часа (p < 0,00001).
Заклучок: Интраперитонеалното аплицирање на bupivacaine дава добра аналгезија во 
постоперативниот период по лапароскопска холецистектомија.
Клучни зборови: лапароскопска холецистектомија, интраперитонеална апликација, bupivacaine.
